NAN
Nanoform Finland
Stock
Stock
ISIN: FI4000330972
Ticker: NANOFH
FI4000330972
NANOFH
Price
Price
CHART BY
Frequently asked questions
What is Nanoform Finland's market capitalization?
The market capitalization of Nanoform Finland is $108.23M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Nanoform Finland?
Nanoform Finland's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.295. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Nanoform Finland's stock?
Currently, 3 analysts cover Nanoform Finland's stock, with a consensus target price of $3.654. Analyst ratings provide insights into the stock's expected performance.
What is Nanoform Finland's revenue over the trailing twelve months?
Over the trailing twelve months, Nanoform Finland reported a revenue of $2.53M.
What is the EBITDA for Nanoform Finland?
Nanoform Finland's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$22.48M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Nanoform Finland?
Nanoform Finland has a free cash flow of -$21.40M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Nanoform Finland have, and what sector and industry does it belong to?
Nanoform Finland employs approximately 165 people. It operates in the Health Care sector, specifically within the Biotechnology industry.
What is the free float of Nanoform Finland's shares?
The free float of Nanoform Finland is 57.35M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $108.23M
- EPS (TTM)
- -$0.295
- Free Float
- 57.35M
- Revenue (TTM)
- $2.53M
- EBITDA (TTM)
- -$22.48M
- Free Cashflow (TTM)
- -$21.40M
Pricing
- 52W span
- $1.129$3.796
Analyst Ratings
The price target is $3.654 and the stock is covered by 3 analysts.
Buy
3
Hold
0
Sell
0
Information
Nanoform Finland Oyj engages in providing expert services in nanotechnology and drug particle engineering for the international pharma industry. It operates through the Europe and United States geographical segments. The company was founded by Edward Hæggström, Kai Falck, Jouko Yliruusi, and Ilkka Aleksi Lassila in 2015 and is headquartered in Helsinki, Finland.
- Employees
- 165
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- ISIN
- FI4000330972
- Primary Ticker
- NANOFH